NCT01847976View on ClinicalTrials.gov

Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Pain
Interventions
DRUG

Doxycycline

Participants will be asked to take 100 mg of Doxycycline by mouth twice a day for 12 weeks.

Trial Locations (1)

K1H 8L6

The Ottawa Hospital Cancer Centre, Ottawa

Sponsors
All Listed Sponsors
collaborator

Canadian Breast Cancer Foundation

OTHER

lead

Ottawa Hospital Research Institute

OTHER